2026-05-15T10:35:02+00:00 2025-06-30 135565207 KPMG LLP 60 South Street Boston MA 02111 990 2024-07-01 263428781 The Broad Institute Inc BROA 6177147000 415 Main Street Cambridge MA 02142 Todd Golub Institute Director 6177147050 2026-05-15 true Kristin Anderson P01231300 6179881000 2026-05-14 2024 2025-03-06 01:10:19Z Todd Golub Institute Director 415 Main Street Cambridge MA 02142 850391383 false X www.broadinstitute.org X 2008 MA SEE SCHEDULE O. 17 16 2676 25 20488429 4868626 697728697 676305601 52829263 67090286 54941889 69578427 25609631 33160112 831109480 846134426 98689042 98808899 0 324313636 323357658 0 0 4224560 329529185 376843980 752531863 799010537 78577617 47123889 2945064927 3514911720 740962746 1119746881 2204102181 2395164839 THE MISSION OF THE BROAD INSTITUTE IS TO PROPEL PROGRESS IN BIOMEDICINE, THROUGH RESEARCH AIMED AT THE UNDERSTANDING AND TREATMENT OF DISEASE AND THE DISSEMINATION OF SCIENTIFIC KNOWLEDGE TO THE SCIENTIFIC COMMUNITY TO BENEFIT THE PUBLIC. WE ARE A RESEARCH ORGANIZATION DEDICATED TO UNDERSTANDING THE ROOTS OF DISEASE AND CLOSING THE GAP BETWEEN NEW BIOLOGICAL INSIGHTS AND IMPACT FOR PATIENTS. false false 629825966 98808899 54166478 See Schedule O 629825966 true true false true false false false false true true true true false true true true false true false false true true true false false false false true true true true false false false false false false false false false false true false false false true true true false false false true 484 0 true 2676 true true true false false false false false false false false false false false X 17 16 true false false false true true true true true false false false true true true true true true true true true true CA MA NY NC PA X X Emme Handy CFOTreasurer 6177147000 415 MAIN STREET Cambridge MA 02142 Todd Golub Institute Director 60.0 1.0 X X 921555 0 60821 Alan Garber Director 1.0 0.0 X 0 0 0 Arthur Levinson Director 1.0 0.0 X 0 0 0 Benjamin Ebert Director (Beg 10/24) 1.0 0.0 X 0 0 0 David Baltimore Director 1.0 0.0 X 0 0 0 Eric E Schmidt Director 1.0 0.0 X 0 0 0 George Daley Director 1.0 0.0 X 0 0 0 Gerun Riley Director 2.0 0.0 X 0 0 0 James Manyika Director 1.0 0.0 X 0 0 0 Laurie Glimcher Director (Until 9/24) 1.0 0.0 X 0 0 0 Margaret Hamburg Director 1.0 0.0 X 0 0 0 Mark Nunnelly Director 1.0 0.0 X 0 0 0 Phillip Sharp Director 1.0 0.0 X 0 0 0 R Martin Chavez Director 1.0 0.0 X 0 0 0 Sally Kornbluth Director 1.0 0.0 X 0 0 0 Seth Klarman Director 1.0 0.0 X 0 0 0 Shirley Tilghman Director 1.0 0.0 X 0 0 0 William Helman Director 1.0 0.0 X 0 0 0 Corrina L Hale Senior Counsel/Clerk 60.0 0.0 X 253925 0 54258 Emme Handy Chief Financial Officer/Treasurer 60.0 0.0 X 407134 0 60331 Laurie Pessah BOD Admin/Assistant Clerk 60.0 0.0 X 181193 0 52117 Wanda Cordova Senior Advisor to the CFO/Assistant Treasurer 60.0 0.0 X 301373 0 31005 Dan Shore Chief Operating Officer 60.0 0.0 X 541221 0 60712 Stacey Gabriel EVP, Platforms and Scientific Execution 60.0 0.0 X 753888 0 61192 Eric Lander Core Institute Member 60.0 0.0 X 702928 0 49277 Michael Christiano Chief Business Officer 60.0 0.0 X 452600 0 65409 Morgan Sheng Co-Director, Stanley Center for Psychiatric Research 60.0 1.0 X 604841 0 63638 Niall Lennon Senior Director, Genomics Platform 60.0 0.0 X 451243 0 60498 Priya McCue Chief Development Officer 60.0 0.0 X 448409 0 60052 6020310 0 679310 1050 false true false Turner Construction Company 2 Seaport Lane Ste 200 Boston MA 02210 Construction 76210748 The Richmond Group Inc 77 Main Street Hopkinton MA 01748 Construction 23717669 EMC CORPORATION 55 CONSTITUTION BLVD FRANKLIN MA 02038 IT Support 6235234 Johnson Marcou & Isaacs LLC PO Box 691 Hoschton GA 02139 Legal 5639914 Wolf Greenfield & Sacks PC 600 Atlantic Avenue Boston MA 02210 Legal 4143492 114 189100655 487204946 6201779 676305601 Research 541700 62156114 49813747 12342367 Admin Fees 541700 1657173 1657173 Use of Facilities 541700 955832 374391 581441 Rebates 541700 283308 283308 Conference registration fees 541700 262251 262251 1775608 1775608 0 0 67090286 28087323 740770 27346553 32945288 32945288 289140 74316 214824 0 214824 214824 45315151 358594 3578403 604238 41736748 -245644 41491104 6823851 34667253 0 0 0 0 0 846134426 54166478 20488429 95173918 86001572 86001572 555150 555150 12252177 12252177 0 0 3518713 1090175 2357839 70699 0 0 0 0 252055133 180229977 69182148 2643008 10345063 8347858 1863576 133629 40565331 32733838 7307503 523990 16873418 13615857 3039604 217957 0 0 0 0 8834363 136839 8697524 0 391766 0 391766 0 0 0 0 0 0 0 10468779 0 10468779 0 23087086 7970416 14721602 395068 971015 152425 780558 38032 2382858 1571783 810160 915 50259952 34060023 16168057 31872 0 0 0 0 84188183 74363245 9792719 32219 3981429 3537306 423553 20570 0 0 0 0 8004019 3673971 4222392 107656 14099356 13497071 602285 0 0 0 0 0 63375423 55609886 7758572 6965 1768014 140552 1627462 0 Materials and Services 102938250 98366273 4570099 1878 Minor Equipment and Rentals 794447 780414 14033 0 Maintenance and Repairs 646787 527420 119265 102 Bad debt (unrecovered collections) 554038 554038 0 98215 57700 40515 0 799010537 629825966 164960011 4224560 4540445 8808379 313346248 418458365 199321010 232324063 115660945 112409559 0 0 0 0 1131894 778315 16406932 14457067 61071800 44741432 1058801598 426058098 600266130 632743500 366798597 274700862 1149494154 1314412563 0 0 0 117026772 461077615 2945064927 3514911720 162610232 127239198 0 0 115627303 129180183 221443350 206717991 7180312 3566863 0 0 0 0 0 0 234101549 653042646 740962746 1119746881 X 708232268 675596729 1495869913 1719568110 0 0 0 0 0 0 2204102181 2395164839 2945064927 3514911720 X 47123889 146361881 -2423112 X false true true true true X 652261340 628985320 686298447 695876757 676305601 3339727465 0 0 652261340 628985320 686298447 695876757 676305601 3339727465 404717755 2935009710 28213226 18575806 60514918 59482149 60580981 227367080 596341 1355680 375908 0 4868626 7196555 0 0 0 0 0 0 3574291100 1153922917 0.82114 0.79803 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false true false false false false false false true 58252 58252 false Schedule C, Part II-B, Line 1 DETAILED DESCRIPTION OF THE LOBBYING ACTIVITY DURING THE PERIOD JULY 1, 2024 THROUGH JUNE 30, 2025, THE BROAD INSTITUTE HAS ENGAGED IN DIRECT INTERACTION WITH LEGISLATORS AND STAFF BY TELEPHONE, EMAIL AND IN PERSON TO FURTHER THE INSTITUTE'S MISSION OF PROPELLING PROGRESS IN BIOMEDICINE THROUGH SCIENTIFIC RESEARCH WITH AIMS TO BENEFIT THE SCIENTIFIC COMMUNITY AND GENERAL PUBLIC. THE BROAD INSTITUTE PAYS MEMBERSHIP DUES TO MEMBER ORGANIZATIONS WHICH MAY ENGAGE IN LOBBYING ACTIVITIES. $3,000 OF THE DUES ARE ATTRIBUTABLE TO LOBBYING ACTIVITIES. false true X 1175501356 85041458 166069911 47012916 1379599809 1027538426 90007110 100397792 42441972 1175501356 960254642 80000014 25975596 38691826 1027538426 965398855 61441617 -33774157 32811673 960254642 688837965 55182361 252348799 30970270 965398855 0.7733 0.2267 false false 25000000 25000000 346781919 150283457 196498462 324689032 76089883 248599149 255966751 180527539 75439212 106363896 19157219 87206677 632743500 Closely-held equity interests Financial derivatives Alternative investments 1314412563 F 1314412563 Beneficial Interest in Trust 1866785 Operating Lease - Right of Use Asset 459210830 Intercompany Receivable Construction in Progress 461077615 Federal Income Taxes Finance Lease Obligation 96003753 Operating lease liabilities 557038893 653042646 X 996741161 146361881 0 0 14713633 161075514 835665647 10468779 0 10468779 846134426 805677502 0 0 0 17135744 17135744 788541758 10468779 0 10468779 799010537 Schedule D, Part IV, Line 2b Explanation of escrow agreement THE BROAD INSTITUTE IS AN AGENT FOR FUNDS OF THE STARR CANCER CONSORTIUM (SCC) WHICH ARE INCLUDED ON FORM 990, PART X, LINE 2. AN OFFSETTING LIABILITY IS REPORTED FOR THE SAME AMOUNT ON FORM 990, PART X, LINE 21. THE SCC IS A COLLABORATIVE RESEARCH FRAMEWORK AMONG FIVE INSTITUTIONS INCLUDING THE BROAD INSTITUTE. Schedule D, Part V, Line 4 Intended uses of endowment funds The Institute's endowment consists of contributions with donor restrictions to be invested in perpetuity to support the Institute's primary mission to propel progress in biomedicine through research aimed at the understanding and treatment of disease, and the dissemination of scientific knowledge to the scientific community to benefit the public. The Institute is a research organization dedicated to understanding the roots of disease and closing the gap between new biological insights and impact for patients. Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnote The Internal Revenue Service has determined that the Institute is an organization described under Internal Revenue Code (the "Code") Section 501(C (3) and, therefore, is exempt from federal income taxes on related income pursuant to Section 501(a) of the Code. Accordingly, no provision for income taxes has been recorded. The Institute recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount of benefit that is greater than fifty percent likely to be realized upon settlement. Changes in measurement are reflected in the period in which the change in judgment occurs. The Institute did not recognize the effect of any uncertain income tax positions for the years ended June 30, 2025 and 2024, respectively. Schedule D, Part XI, Line 2(d) Other revenues in audited financial statements not in form 990 THE INSTITIUTE RECOGNIZED CHANGES IN THE INSTITUTE'S BENEFICIAL INTEREST IN TRUST OF $161,567 IN NONOPERATING ACTIVITIES IN ITS FINANCIAL STATEMENTS. - 161567 RENTAL EXPENSES OF $74,316 ARE REPORTED AS EXPENSES IN THE INSTITUTE'S FINANCIAL STATEMENTS. - 74316 THE INSTITUTE RECOGNIZED A GAIN OF $9,665,766 FROM THE COUNT ME IN, INC. MERGER IN NONOPERATING ACTIVITIES IN ITS FINANCIAL STATEMENTS. - 9665766 THE INSTITUTE RECOGNIZED A LOSS OF $716,025 ON UNCOLLECTIBLE PLEDGES IN NONOPERATING ACTIVITIES IN ITS FINANCIAL STATEMENTS. - -716025 THE INSTITUTE RECOGNIZED A LOSS OF $5,528,009 ON UNCOLLECTIBLE GRANTS IN OPERATING ACTIVITIES IN ITS FINANCIAL STATEMENTS. - 5528009 Schedule D, Part XII, Line 2(d) Other expenses in audited financial statements not in form 990 RENTAL EXPENSES OF $74,316 ARE REPORTED AS EXPENSES IN THE INSTITUTE'S FINANCIAL STATEMENTS. - 74316 REVERSAL OF GRANT EXPENSES FOR $544,938 ARE REPORTED AS CONTRA EXPENSES IN THE INSTITUTE'S FINANCIAL STATEMENTS. - -545933 THE INSTITUTE RECOGNIZED A LOSS OF $17,607,361 ON UNCOLLECTIBLE GRANTS IN OPERATING ACTIVITIES IN ITS FINANCIAL STATEMENTS. - 17607361 true East Asia and the Pacific Grants to Recipients in the Region 2074393 Europe (Including Iceland and Greenland) Grants to Recipients in the Region 4508915 South Asia Grants to Recipients in the Region 2336047 Sub-Saharan Africa Grants to Recipients in the Region 2108291 North America (Canada & Mexico only) Grants to Recipients in the Region 1224531 Central America and the Caribbean Program Services RESEARCH AND SEMINAR 6822 East Asia and the Pacific Program Services RESEARCH AND SEMINAR 408572 Europe (Including Iceland and Greenland) 3 Program Services RESEARCH AND SEMINAR 851020 Middle East and North Africa Program Services RESEARCH AND SEMINAR 10229 North America (Canada & Mexico only) Program Services RESEARCH AND SEMINAR 110441 South America Program Services RESEARCH AND SEMINAR 2101 South Asia Program Services RESEARCH AND SEMINAR 10501 Sub-Saharan Africa 1 Program Services RESEARCH AND SEMINAR 209858 North America (Canada & Mexico only) Fundraising 12526 Europe (Including Iceland and Greenland) Fundraising 12179 East Asia and the Pacific Fundraising 4616 Central America and the Caribbean Investments 76494161 Europe (Including Iceland and Greenland) Investments 91283909 North America (Canada & Mexico only) Investments 3423359 0 4 0 0 0 4 13891042 171201429 185092471 East Asia and the Pacific RESEARCH SUBAWARD 61250 Wire East Asia and the Pacific RESEARCH SUBAWARD 35290 Wire East Asia and the Pacific RESEARCH SUBAWARD 512940 Wire East Asia and the Pacific RESEARCH SUBAWARD 80000 ACH- Bank TR East Asia and the Pacific RESEARCH SUBAWARD 464113 Wire East Asia and the Pacific RESEARCH SUBAWARD 16413 Wire East Asia and the Pacific RESEARCH SUBAWARD 20000 Wire East Asia and the Pacific RESEARCH SUBAWARD 230000 Wire East Asia and the Pacific RESEARCH SUBAWARD 36137 Wire East Asia and the Pacific RESEARCH SUBAWARD 93251 ACH- Bank TR East Asia and the Pacific RESEARCH SUBAWARD 62250 Wire East Asia and the Pacific RESEARCH SUBAWARD 462749 Wire Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 128845 Wire Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 384828 ACH- Bank TR Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 195548 Wire Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 43200 ACH- Bank TR Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 283594 ACH- Bank TR Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 64621 ACH- Bank TR Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 247064 ACH- Bank TR Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 49214 Wire Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 104314 Wire Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 335067 Wire Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 29190 Wire Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 224947 Wire Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 534125 Wire Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 80514 Wire Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 927778 Wire Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 31556 Wire Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 24147 Wire Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 300000 Wire Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 68371 Wire Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 250005 Wire Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 31967 Wire Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 28000 Wire Europe (Including Iceland and Greenland) RESEARCH SUBAWARD 99994 Wire North America (Canada & Mexico only) RESEARCH SUBAWARD 159820 Wire North America (Canada & Mexico only) RESEARCH SUBAWARD 405193 Wire North America (Canada & Mexico only) RESEARCH SUBAWARD 59333 Wire North America (Canada & Mexico only) RESEARCH SUBAWARD 213148 ACH- Bank TR North America (Canada & Mexico only) RESEARCH SUBAWARD 190440 Check North America (Canada & Mexico only) RESEARCH SUBAWARD 79206 ACH- Bank TR North America (Canada & Mexico only) RESEARCH SUBAWARD 41917 Wire North America (Canada & Mexico only) RESEARCH SUBAWARD 59333 Wire North America (Canada & Mexico only) RESEARCH SUBAWARD 16141 Wire South Asia RESEARCH SUBAWARD 165830 Wire South Asia RESEARCH SUBAWARD 575880 ACH- Bank TR South Asia RESEARCH SUBAWARD 1594337 ACH- Bank TR Sub-Saharan Africa RESEARCH SUBAWARD 53621 Wire Sub-Saharan Africa RESEARCH SUBAWARD 934496 Wire Sub-Saharan Africa RESEARCH SUBAWARD 540156 Wire Sub-Saharan Africa RESEARCH SUBAWARD 427668 Wire Sub-Saharan Africa RESEARCH SUBAWARD 152350 Wire 40 12 Tuition Europe (Including Iceland and Greenland) 1 18297 Fellowships Europe (Including Iceland and Greenland) 4 23729 true false true true true true Schedule F, Part I, Line 2 Procedures for monitoring use of grant funds THE INSTITUTE ASSIGNS RESPONSIBILITY FOR MONITORING THE USE OF GRANT FUNDS OUTSIDE OF THE UNITED STATES TO ITS OFFICE OF SPONSORED RESEARCH. THIS OFFICE MONITORS ALL GRANT MAKING ACTIVITY INCLUDING ALL APPLICABLE COMPLIANCE REGULATIONS. MONITORING INCLUDES PERIODIC REVIEWS OF BUDGET TO ACTUAL REPORTS BY BOTH THE OFFICE OF SPONSORED RESEARCH AND THE PRINCIPAL INVESTIGATOR TO ENSURE FUNDS ARE USED ACCORDING TO THE AGREEMENT. UPON IDENTIFICATION OF SUBRECIPIENTS THAT MANDATE CLOSER SCRUTINY, INCLUDING FOREIGN AND FOR-PROFIT SUBRECIPIENTS, THE INSTITUTE IMPLEMENTS ADDITIONAL MONITORING ACTIONS TO ENSURE COMPLIANCE WITH FEDERAL RULES AND REGULATIONS AND INSTITUTIONAL RISK MANAGEMENT PRACTICES. Schedule F, Part I, Line 3 Method used to account for expenditures on org's financial statements CENTRAL AMERICA AND THE CARIBBEAN-Accrual; EAST ASIA AND THE PACIFIC-Accrual; EUROPE (INCLUDING ICELAND AND GREENLAND)-Accrual; MIDDLE EAST AND NORTH AFRICA-Accrual; NORTH AMERICA (CANADA & MEXICO ONLY)-Accrual; SOUTH AMERICA-Accrual; SOUTH ASIA-Accrual; SUB-SAHARAN AFRICA-Accrual true 3 Point Bio LLC 4 Dana Rd Boxford MA 01921 364806076 N/A 808638 RESEARCH Addgene 75 Sidney St Ste 550A Cambridge MA 02139 900133592 501(c)(3) 520667 RESEARCH AmplifyBio LLC 1425 PC Grgsville Rd W Jefferson OH 43162 862301671 N/A 366700 RESEARCH Beth Israel Deaconess Medical Ctr 330 Brookline Ave Boston MA 02215 042103881 501(c)(3) 10645360 RESEARCH BlueHalo LLC 410 Jan Davis Dr NW Huntsville AL 35806 630985776 N/A 599284 RESEARCH Boston University 85 E Newton St Ste 931 Boston MA 02118 042103547 501(c)(3) 85967 RESEARCH Brigham & Women's Hospital 75 Francis Street Boston MA 02115 042312909 501(c)(3) 1473284 RESEARCH Brown University 69 Brown St Box 1822 Providence RI 02912 050258809 501(c)(3) 482851 RESEARCH Children's Hospital of Boston 300 Longwood Avenue Boston MA 02115 042774441 501(c)(3) 1297455 RESEARCH Color Health Inc 831 Mitten Rd Ste 100F Burlingame CA 94010 463353585 N/A 2019915 RESEARCH Columbia University 615 W 131st St MC 8741 New York NY 10025 135598093 501(c)(3) 301118 RESEARCH Dana Farber Cancer Institute BP451 450 Brookline Avenue Boston MA 02215 042263040 501(c)(3) 5131414 RESEARCH Duke University PO Box 602651 Charlotte NC 282602651 560532129 501(c)(3) 89726 RESEARCH Emory University 1599 Clifton Road NE 4th Fl Atlanta GA 30322 580566256 503(c)(3) 183276 RESEARCH Emugen Therapeutics LLC 242 Homer Street Newton MA 02459 863092756 N/A 3510000 RESEARCH Eurofins DiscoverX Products LLC 42501 Albrae Street Fremont CA 94538 843528205 N/A 211753 RESEARCH Fathom Information Design (Ben Fry LLC) 300 Cambridge Street Boston MA 02114 271573165 N/A 1820203 RESEARCH Feinstein Institute for Medical Research 972 BRUSH HOLLOW ROAD Suite 5th FL Westbury NY 11590 112673595 501(c)(3) 230000 RESEARCH Fred Hutchinson Cancer Center 1100 Fairview Avenue N PO Box 19 Seattle WA 98109 911935159 501(c)(3) 204424 RESEARCH Geisinger Clinic 100 North Academy Avenue Danville PA 17822 236291113 501(c)(3) 1980824 RESEARCH General Dynamics Information Technology Inc 3150 Fairview Park Drive Falls Church VA 22042 541194322 N/A 570743 RESEARCH Harvard Pilgrim Health Care Inc 1 Wellness Way Canton MA 02021 042663394 501(c)(4) 41500 RESEARCH Harvard University 1350 Massachusetts Avenue Cambridge MA 021383800 042103580 501(c)(3) 15751441 RESEARCH Icahn School of Medicine at Mount Sinai 1 Gustave L Levy Place New York NY 10029 136171197 501(c)(3) 531666 RESEARCH Indiana University 509 East 3rd Street Bloomington IN 474013654 356001673 501(c)(3) 126372 RESEARCH Johns Hopkins University 3400 North Charles Street Baltimore MD 212182686 520595110 501(c)(3) 480626 RESEARCH Joslin Diabetes Ctr One Joslin Pl Boston MA 02215 042203836 501(c)(3) 1565106 RESEARCH Lundquist Institute 1124 West Carson Street Torrance CA 90502 952138184 501(c)(3) 24985 RESEARCH Massachusetts Department of Public Health 1 Ashburton Pl Fl 9 Boston MA 02108 046002284 STATE OF MA 285179 RESEARCH Massachusetts Eye & Ear Infirmary 243 Charles Street Boston MA 02114 042103591 501(c)(3) 362493 RESEARCH Massachusetts General Hospital 55 Fruit Street Boston MA 021142517 041564655 501(c)(3) 11433749 RESEARCH Massachusetts Institute of Technology 77 Massachusetts Avenue Cambridge MA 02139 042103594 501(c)(3) 7032375 RESEARCH Mayo Clinic 200 First Street SW Rochester MN 55905 416011702 501(c)(3) 96066 RESEARCH McLaughlin Research Institute for Biomedical Sciences 1520 23rd Street South Great Falls MT 59405 810459235 501(c)(3) 168347 RESEARCH McLean Hospital 115 Mill Street Belmont MA 02478 042697981 501(c)(3) 679305 RESEARCH National Alliance on Mental Illness 4301 Wilson Blvd Suite 300 Arlington VA 22203 431201653 501(c)(3) 25000 RESEARCH Nationwide Children's Hospital 700 Childrens Drive Columbus OH 43205 311036372 501(c)(3) 222109 RESEARCH New York Genome Center Inc 101 Avenue of the Americas 7th Fl New York NY 10013 800631734 501(c)(3) 1089068 RESEARCH Northeastern University 360 Huntington Avenue Boston MA 02115 041679980 501(c)(3) 261079 RESEARCH Northwestern University 633 Clark St Evanston IL 60208 362167817 501(c)(3) 64340 RESEARCH Oklahoma Medical Research Foundation 825 NE 13th Street Oklahoma City OK 73104 730580274 501(c)(3) 63398 RESEARCH Princeton University 701 Carnegie Center Princeton NJ 08540 210634501 501(c)(3) 43855 RESEARCH Purdue University 2550 Northwestern Ave Suite 1120 West Lafayette IN 47906 356002041 501(c)(3) 50000 RESEARCH Seven Bridges Genomics Inc 529 Main Street Suite 6610 Charlestown MA 02129 453415885 N/A 155250 RESEARCH St Jude Children's Research Hospital Inc 262 Danny Thomas Place Memphis TN 381053678 620646012 501(c)(3) 241232 RESEARCH Stanford University 485 Broadway Redwood City CA 94063 941156365 501(c)(3) 896807 RESEARCH The Inspire Project Inc 329 Pine Tree Road Venice FL 34293 823692406 501(c)(3) 630527 RESEARCH The Jackson Laboratory 600 Main Street Bar Harbor ME 04609 010211513 501(c)(3) 271488 RESEARCH The Ohio State University 1645 Neil Avenue Columbus OH 43210 316025986 501(c)(3) 99055 RESEARCH The Regents of the University of Michigan 3003 South State Street Ann Arbor MI 48109 386006309 STATE OF MICHIGAN 916970 RESEARCH The Rockefeller University 1230 York Avenue New York NY 10065 131624158 501(c)(3) 106535 RESEARCH The Univ of Massachusetts Medical School 55 North Lake Avenue Worcester MA 01655 043167352 STATE OF MA 512901 RESEARCH The University of Chicago 6054 South Drexel Avenue Chicago IL 60637 362177139 501(c)(3) 67540 RESEARCH The University of Mississippi Medical Center 2500 North State Street Jackson MS 392164505 646008520 STATE OF MISSISSIPPI 188862 RESEARCH The University of North Carolina at Chapel Hill 104 Airport Drive Suite 2200 CB 13 Chapel Hill NC 275991350 566001393 501(c)(3) 88555 RESEARCH The University of Texas MD Anderson Cancer Center 1515 Holcombe Boulevard Houston TX 770304009 746001118 STATE OF TEXAS 48400 RESEARCH Trustees of Tufts College 169 Holland Street Somerville MA 02144 042103634 501(c)(3) 159879 RESEARCH University of California Berkeley 2195 Hearst Ave RM 130 MC 1103 Berkeley CA 94720 946002123 501(c)(3) 300837 RESEARCH University of California Davis 1 Shields Avenue Davis CA 95616 946036494 501(c)(3) 166333 RESEARCH University of California Los Angeles 405 Hilgard Avenue Los Angeles CA 90095 956006143 STATE OF CALIFORNIA 81664 RESEARCH University of California San Diego 9500 Gilman Drive La Jolla CA 92093 956006144 STATE OF CALIFORNIA 1303734 RESEARCH University of California Santa Cruz 1156 High Street Santa Cruz CA 95064 941539563 STATE OF CALIFORNIA 962500 RESEARCH University of Colorado Denver 1800 North Grant Street Suite 725 Denver CO 802031114 846049811 501(c)(3) 19676 RESEARCH University of Maryland Baltimore 620 West Lexington Street Baltimore MD 21201 526002033 170(c)(1) 507997 RESEARCH University of Pennsylvania 3451 Walnut Street Philadelphia PA 19104 231352685 501(c)(3) 735239 RESEARCH University of Southern California 1540 Alcazar Street Los Angeles CA 90033 951642394 501(c)(3) 54243 RESEARCH University of Texas San Antonio 1 UTSA Circle San Antonio TX 782491644 741717115 170(c)(1) 273443 RESEARCH University of Virginia PO Box 400202 Charlottesville VA 22904 546001796 501(c)(3) 35000 RESEARCH University of Wisconsin-Madison 21 North Park Street Suite 6401 Madison WI 537151218 396006492 501(c)(3) 647587 RESEARCH Utah State University 1415 Old Main Hill Logan UT 84322 876000528 501(c)(3) 8419 RESEARCH Vanderbilt University Medical Center 1161 21st Avenue South Nashville TN 372325545 352528741 501(c)(3) 691689 RESEARCH Varilly Sciences US Inc 16192 Coastal Highway Lewes DE 19958 881768639 N/A 190575 RESEARCH Wake Forest University Health Sciences 1834 Wake Forest Road WinstonSalem NC 27109 223849199 501(c)(3) 78258 RESEARCH Washington University in St Louis 660 South Euclid Avenue St Louis MO 63110 430653611 501(c)(3) 423897 RESEARCH Weill Cornell Medical College 445 East 69th Street New York NY 10021 131623978 501(c)(3) 375694 RESEARCH Whitehead Institute 455 Main Street Cambridge MA 02142 061043412 501(c)(3) 1004550 RESEARCH Yale University PO Box 1873 New Haven CT 065208239 060646973 501(c)(3) 824574 RESEARCH 55 22 FELLOWSHIPS 44 155150 PRIZE 1 400000 Schedule I, Part I, Line 2 Procedures for monitoring use of grant funds THE INSTITUTE ASSIGNS RESPONSIBILITY FOR MONITORING THE USE OF GRANT FUNDS INSIDE OF THE UNITED STATES TO ITS OFFICE OF SPONSORED RESEARCH. THIS OFFICE MONITORS ALL GRANT MAKING ACTIVITY INCLUDING ALL APPLICABLE COMPLIANCE REGULATIONS. MONITORING INCLUDES PERIODIC REVIEWS OF BUDGET TO ACTUAL REPORTS BY BOTH THE OFFICE OF SPONSORED RESEARCH AND THE PRINCIPAL INVESTIGATOR TO ENSURE FUNDS ARE USED ACCORDING TO THE AGREEMENT. EXPENSES ARE ACCOUNTED FOR ON AN ACCRUAL BASIS. UPON IDENTIFICATION OF SUBRECIPIENTS THAT MANDATE CLOSER SCRUTINY, INCLUDING FOR-PROFIT SUBRECIPIENTS, THE INSTITUTE IMPLEMENTS ADDITIONAL MONITORING ACTIONS TO ENSURE COMPLIANCE WITH FEDERAL RULES AND REGULATIONS AND INSTITUTIONAL RISK MANAGEMENT PRACTICES. X X X false true X X X X X false false false false false false false false false Todd Golub Institute Director 893267 0 0 0 28288 0 27300 0 33521 0 982376 0 0 0 Emme Handy Chief Financial Officer/Treasurer 406714 0 0 0 420 0 27062 0 33269 0 467465 0 0 0 Wanda Cordova Senior Advisor to the CFO/Assistant Treasurer 267412 0 10000 0 23961 0 23480 0 7525 0 332378 0 0 0 Corrina L Hale Senior Counsel/Clerk 252344 0 0 0 1581 0 20757 0 33501 0 308183 0 0 0 Laurie Pessah BOD Admin/Assistant Clerk 180160 0 0 0 1033 0 14946 0 37171 0 233310 0 0 0 Stacey Gabriel EVP, Platforms and Scientific Execution 615898 0 112500 0 25490 0 27300 0 33892 0 815080 0 0 0 Dan Shore Chief Operating Officer 515146 0 0 0 26075 0 27300 0 33412 0 601933 0 0 0 Eric Lander Core Institute Member 695345 0 0 0 7583 0 27300 0 21977 0 752205 0 0 0 Morgan Sheng Co-Director, Stanley Center for Psychiatric Research 352448 0 0 0 252393 0 27300 0 36338 0 668479 0 0 0 Michael Christiano Chief Business Officer 448310 0 0 0 4290 0 30978 0 34431 0 518009 0 0 0 Niall Lennon Senior Director, Genomics Platform 426280 0 0 0 24963 0 27300 0 33198 0 511741 0 0 0 Priya McCue Chief Development Officer 423272 0 0 0 25137 0 27300 0 32752 0 508461 0 0 0 Schedule J, Part I, Line 1a First-class or charter travel FIRST-CLASS TRAVEL FOR OFFICERS AND CERTAIN EMPLOYEES OCCURS IN LIMITED SITUATIONS. THIS TRAVEL IS FOR BUSINESS PURPOSES, THEREFORE, THE VALUE IS NOT TREATED AS TAXABLE WAGES. THE INSTITUTE DIRECTOR AND CORE INSTITUTE MEMBER WERE THE ONLY LISTED INDIVIDUALS WHO USED FIRST-CLASS TRAVEL DURING THE CALENDAR YEAR ENDED DECEMBER 31, 2024. Schedule J, Part I, Line 1a Tax indemnification and gross-up payments HOUSING AND TAX GROSS UP PAYMENTS ARE REFLECTED IN THE "OTHER REPORTABLE COMPENSATION" AMOUNT ON SCHEDULE J, PART II, COLUMN B (III) AND ARE CONSIDERED TAXABLE COMPENSATION TO THE INDIVIDUAL. THESE BENEFITS WERE REVIEWED AND APPROVED BY APPOINTED LEADERSHIP WITHIN THE INSTITUTE. Schedule J, Part I, Line 1a Housing allowance or residence for personal use AS AN ELEMENT OF HIS COMPENSATION ARRANGEMENT, THE CO-DIRECTOR, STANLEY CENTER FOR PSYCHIATRIC RESEARCH, RECEIVED A HOUSING ALLOWANCE DURING THE CALENDAR YEAR ENDED DECEMBER 31, 2024. THE CO-DIRECTOR, STANLEY CENTER FOR PSYCHIATRIC RESEARCH, RECEIVED GROSS-UP PAYMENTS ON CERTAIN AMOUNTS FOR TAX PURPOSES. A Mass Development Finance Agency - Series 2017 043431814 57584X3E9 2017-11-16 291123863 Defeasance of prior bond issue false false false A 62200000 291123863 2336518 288787345 2017 false true true true A false true false false true true 0.0 0.0 0.0 false false 0 false false A false false false true false false 0 false false false 0 false false true A true Schedule K, Part IV, Line 2c ARBITRAGE REBATE COMPUTATION THE MASS DEVELOPMENT FINANCE AGENCY REVENUE BONDS 2017 SERIES REBATE COMPUTATION WAS LAST PERFORMED FOR THE PERIOD ENDING JUNE 30, 2022. NO REBATE AMOUNT WAS DUE. THE NEXT REBATE COMPUTATION WILL BE PERFORMED FOR THE PERIOD ENDING JUNE 30, 2027, NO LATER THAN AUGUST 30, 2027. 3 6201779 Market value 0 false true false Schedule M, Part I COLUMN (B) The organization is reporting the number of contributions in column (b). Form 990, Part I, Line 1 ORGANIZATION'S MISSION THE MISSION OF THE BROAD INSTITUTE IS TO PROPEL PROGRESS IN BIOMEDICINE, THROUGH RESEARCH AIMED AT THE UNDERSTANDING AND TREATMENT OF DISEASE, AND THE DISSEMINATION OF SCIENTIFIC KNOWLEDGE TO THE SCIENTIFIC COMMUNITY TO BENEFIT THE PUBLIC. WE ARE A RESEARCH ORGANIZATION DEDICATED TO UNDERSTANDING THE ROOTS OF DISEASE AND CLOSING THE GAP BETWEEN NEW BIOLOGICAL INSIGHTS AND IMPACT FOR PATIENTS. Form 990, Part I, Line 6 VOLUNTEERS THE BROAD INSTITUTE DOES NOT FORMALLY TRACK VOLUNTEERS BUT HAS INCLUDED THE NUMBER OF BOARD MEMBERS AND COMMITTEE MEMBERS THAT ARE UNCOMPENSATED. Form 990, Part III, Line 4a STATEMENT OF PROGRAM SERVICE ACCOMPLISHMENTS THE BROAD INSTITUTE OPERATES FOR EDUCATIONAL AND SCIENTIFIC PURPOSES TO IMPROVE HUMAN HEALTH BY USING GENOMICS TO ADVANCE THE UNDERSTANDING OF THE BIOLOGY AND TREATMENT OF HUMAN DISEASE, AND TO HELP LAY THE GROUNDWORK FOR A NEW GENERATION OF THERAPIES. THE INSTITUTE DEFINES A NEW COLLABORATIVE MODEL FOR BIOMEDICAL RESEARCH, BRINGING TOGETHER EXTRAORDINARY SCIENTISTS ACROSS HARVARD, MIT AND HARVARD-AFFILIATED HOSPITALS AND USES NEW APPROACHES THAT COMBINE BIOLOGY, CHEMISTRY, MATHEMATICS, COMPUTATION AND ENGINEERING WITH MEDICAL SCIENCE AND CLINICAL RESEARCH. ITS SCIENTISTS ARE COMMITTED TO UNDERSTANDING THE FUNDAMENTAL BASIS OF GENOME AND CELL BIOLOGY, AND TO DEVELOPING TRANSFORMATIVE NEW APPROACHES TO BIOMEDICAL RESEARCH. SCIENTIFIC AREAS INCLUDE CHEMICAL BIOLOGY AND THERAPEUTICS SCIENCE, DRUG DISCOVERY, GENOME REGULATION, CELLULAR CIRCUITRY AND EPIGENOMICS, IMMUNOLOGY, MEDICAL AND POPULATION GENETICS, AND METABOLISM. BROAD'S RESEARCHERS BRING EXPERTISE IN DIFFERENT TECHNOLOGY AREAS, CALLED PLATFORMS, TO COLLABORATE ON CHALLENGING PROJECTS AND DEVELOP NEW TOOLS AND GENERATE DATA AND INSIGHTS AT A SCALE THAT COULD NOT BE DONE WITHIN A TYPICAL RESEARCH LABORATORY. TECHNOLOGY AREAS INCLUDE DATA SCIENCES, GENETIC PERTURBATION, GENOMICS, IMAGING, METABOLOMICS AND PROTEOMICS. THE INSTITUTE IS FOCUSED ON USING COLLABORATIVE APPROACHES TO ACCELERATE SCIENCE EVERYWHERE, DRIVE DOWN THE COST OF RESEARCH, AND MAKE FOUNDATIONAL ADVANCES IN A NUMBER OF DISEASE AREAS. THESE AREAS INCLUDE CANCER, CARDIOVASCULAR DISEASE, DIABETES, INFECTIOUS DISEASE AND MICROBIOME, KIDNEY DISEASE, OBESITY, PSYCHIATRIC DISORDERS AND RARE DISEASE. THE BROAD INSTITUTE IS COMMITTED TO MAKING THE EXTENSIVE DATA, METHODS, AND TECHNOLOGIES IT GENERATES SECURELY, RAPIDLY AND READILY ACCESSIBLE TO THE SCIENTIFIC COMMUNITY TO DRIVE BIOMEDICAL PROGRESS AROUND THE WORLD. THE BROAD INSTITUTE HOLDS AN ANNUAL SCIENTIFIC RETREAT, A MULTI-DAY MEETING FEATURING PRESENTATIONS AND POSTERS ON A VARIETY OF RESEARCH PROJECTS ACROSS THE INSTITUTE. IN 2024, THE RETREAT WAS ATTENDED BY APPROXIMATELY 2,200 PARTICIPANTS FROM THE COMMUNITY IN PERSON. BROAD INSTITUTE OPERATES THE BROAD DISCOVERY CENTER, A FREE EDUCATIONAL SPACE OPEN TO THE PUBLIC. THERE, BROAD SHOWCASES HOW RESEARCHERS IN KENDALL SQUARE AND AROUND THE WORLD ARE SEEKING TO UNDERSTAND AND TREAT HUMAN DISEASE. IN 2024, APPROXIMATELY 3,000 STUDENTS AND OTHERS VISITED THE DISCOVERY CENTER. THE BROAD'S EDUCATIONAL OUTREACH PROGRAM ENGAGES BOSTON-CAMBRIDGE AREA HIGH SCHOOL STUDENTS IN SCIENTIFIC RESEARCH BY PROVIDING SUMMER INTERNSHIPS AND SEMESTER-LONG RESEARCH PROJECTS. IN 2024, 18 HIGH SCHOOL STUDENTS PARTICIPATED IN A SUMMER SCHOLARS PROGRAM AND 15 HIGH SCHOOL STUDENTS PARTICIPATED IN A CAREER EXPLORERS PROGRAM DURING THE ACADEMIC YEAR. IN 2024, AS PART OF THE NINTH ANNUAL BROAD SCIENTISTS IN THE CLASSROOM PROGRAM WITH CAMBRIDGE PUBLIC SCHOOLS, BROAD SCIENTISTS VISITED GRADE LEVEL CLASSROOMS AND WORKED WITH STUDENTS THROUGHOUT SCIENCE UNITS. BROAD SERVED APPROXIMATELY 385 STUDENTS THROUGHOUT THIS INITIATIVE. BROAD VOLUNTEERS MENTORED 44 STUDENTS IN THE BIO-CODING CLUB DESIGNED TO ENGAGE 6-8 GRADERS IN THE FIELD OF BIOLOGY. ALSO IN 2024, BROAD PARTICPATED IN SEVERAL EDUCATIONAL EVENTS THROUGHOUT THE LOCAL COMMUNITY. BROAD SCIENTISTS PARTICIPATED IN TALKS AND PRESENTATIONS TO VARIOUS GROUPS ACROSS THE COMMUNITY SUCH AS CAMBRIDGE CITY COUNCIL CANDIDATES, HIGH SCHOOL EDUCATORS AND HIGH SCHOOL AND UNDERGRADUATE STUDENTS. BROAD HOSTED EDUCATIONAL EVENTS SUCH AS STEAM IT UP, COMPUTER SCIENCE PLAYGROUND, A CAMBRIDGE SCIENCE FESTIVAL BOOTH, AND TAKE YOUR LITTLE BROADIE TO WORK DAY, REACHING APPROXIMATELY 593 STUDENTS. BROAD SCIENTISTS ALSO LEAD 5 EDUCATIONAL TOURS DURING THE ACADEMIC YEAR WITH APPOXIMATELY 92 STUDENTS IN ATTENDANCE. TO HELP INSPIRE YOUNG PEOPLE AND OFFER OPPORTUNITIES TO STUDENTS INTERESTED IN BIOMEDICAL RESEARCH FROM ACROSS MANY BACKGROUNDS, BROAD OFFERS PROGRAMS FOR INDIVIDUALS AT DIFFERENT STAGES OF THEIR EDUCATION AND CAREERS. IN 2024, 33 HIGH SCHOOL STUDENTS, 21 UNDERGRADUATE STUDENTS AND 43 FACULTY MEMBERS PARTICIPATED IN THESE PROGRAMS. Form 990, Part VI, Line 2 RELATIONSHIPS AMONG PHILLIP SHARP IS AN EMPLOYEE OF MIT AND SALLY KORNBLUTH IS THE PRESIDENT OF MIT; THEREFORE, THEY HAVE A BUSINESS RELATIONSHIP. BOTH ARE DIRECTORS AT THE BROAD INSTITUTE. GEORGE Q. DALEY IS AN EMPLOYEE OF HARVARD, ALAN GARBER IS THE PRESIDENT OF HARVARD, AND SHIRLEY TILGHMAN IS A FELLOW OF HARVARD; THEREFORE, THEY HAVE A BUSINESS RELATIONSHIP. ALL ARE/WERE DIRECTORS AT THE BROAD INSTITUTE. SHIRLEY TILGHMAN IS THE CHAIR OF CALICO'S SCIENTIFIC BOARD AND ARTHUR LEVINSON IS THE CEO OF CALICO; THEREFORE, THEY HAVE A BUSINESS RELATIONSHIP. BOTH ARE DIRECTORS AT THE BROAD INSTITUTE. Form 990, Part VI, Line 6 Classes of members or stockholders THE MEMBERS OF THE BROAD INSTITUTE CONSIST OF MIT, HARVARD, AND THE ELI AND EDYTHE BROAD FOUNDATION. Form 990, Part VI, Line 7a Members or stockholders electing members of governing body BROAD MEMBERS (HARVARD, MIT AND THE BROAD FOUNDATION) EXERCISE ALL POWERS CONSISTENT WITH THE ACTIVITIES AND AFFAIRS OF THE BROAD INSTITUTE. Form 990, Part VI, Line 7b Decisions requiring approval by members or stockholders THE MEMBERS HAVE ALL POWERS AND RIGHTS AS ARE VESTED IN THEM BY LAW, THE ARTICLES OF ORGANIZATION AND THE BY-LAWS, WHICH INCLUDE AMENDMENTS TO THE BY-LAWS AND ARTICLES OF INCORPORATION, THE ELECTION OR REPLACEMENT OF DIRECTORS AND DISSOLUTION OF THE INSTITUTE. THE MEMBERS SHALL HOLD AN ANNUAL MEETING FOR ELECTION OF DIRECTORS AND FOR THE CONDUCT OF SUCH OTHER BUSINESS AS MAY COME BEFORE THE MEETING. Form 990, Part VI, Line 11b Review of form 990 by governing body THE BROAD INSTITUTE'S FORM 990 WAS PREPARED WITH THE ASSISTANCE OF THE INSTITUTE'S AUDITORS, KPMG LLP. THE DRAFT FORM 990 WAS PROVIDED TO THE INSTITUTE'S SENIOR MANAGEMENT AND AUDIT, RISK AND COMPLIANCE COMMITTEE OF THE BOARD FOR REVIEW AND COMMENT. THE FULL BOARD RECEIVED A COMPLETED COPY OF THE FORM 990 PRIOR TO THE FORM BEING FILED WITH THE IRS. Form 990, Part VI, Line 12c Conflict of interest policy EACH DIRECTOR, OFFICER, AND KEY EMPLOYEE HAS A DUTY TO PLACE THE INTEREST OF THE INSTITUTE FOREMOST IN ANY DEALING WITH THE INSTITUTE AND HAS A CONTINUING RESPONSIBILITY TO COMPLY WITH THE REQUIREMENTS OF THIS POLICY. PROMPTLY FOLLOWING THEIR ELECTION OR APPOINTMENT, AND THEREAFTER NOT LATER THAN THE FIRST DAY OF DECEMBER OF EACH YEAR, EACH DIRECTOR, OFFICER, AND KEY EMPLOYEE SHALL ACKNOWLEDGE THEIR FAMILIARITY WITH THIS POLICY AND SHALL DISCLOSE IN WRITING TO THE CHAIRMAN OF THE BOARD ANY EXISTING FINANCIAL OR OTHER MATERIAL INTERESTS SUBJECT TO THIS POLICY BY COMPLETING A CONFLICT OF INTEREST DISCLOSURE STATEMENT. THE CONFLICT OF INTEREST DISCLOSURE STATEMENTS SHALL BE REVIEWED BY THE CHAIRMAN OF THE BOARD. ANY ISSUES NOT PREVIOUSLY DISCLOSED SHALL BE REFERRED BY THEM TO THE BOARD OR APPROPRIATE COMMITTEE. THE CONFLICT OF INTEREST DISCLOSURE STATEMENTS SHALL BE RETAINED IN THE CONFIDENTIAL FILES OF THE CHAIRMAN OF THE BOARD. IF A DIRECTOR, OFFICER, OR KEY EMPLOYEE DISCLOSES A CONFLICT OF INTEREST TO A PROPOSED OR EXISTING ARRANGEMENT, THE INSTITUTE'S POLICY PLACES CERTAIN RESTRICTIONS ON THEIR ABILITY TO PARTICIPATE IN THE GOVERNING BODY'S DELIBERATIONS AND DECISIONS AROUND THE ARRANGEMENT. IF AN EMPLOYEE WITH THE AUTHORITY TO INFLUENCE BUSINESS DECISIONS DISCLOSES A CONFLICT OF INTEREST RELATED TO A PROPOSED BUSINESS DECISION, THE INSTITUTE'S POLICY PLACES CERTAIN RESTRICTIONS ON THEIR ABILITY TO PARTICIPATE IN THE DECISION-MAKING PROCESS. Form 990, Part VI, Line 15a Process to establish compensation of top management official THE BROAD INSTITUTE MOST RECENTLY ENGAGED A CONSULTING FIRM TO CONDUCT AN INDEPENDENT STUDY FOR THE COMPENSATION OF THE INSTITUTE DIRECTOR IN 2022 AND 2024. THE STUDY FINDINGS WERE PRESENTED TO THE LEADERSHIP, PERSONNEL POLICY AND BOARD GOVERNANCE COMMITTEE FOR REVIEW AND APPROVAL. THE BOARD OF DIRECTORS' DELIBERATIONS AND DECISIONS WERE CONTEMPORANEOUSLY DOCUMENTED. Form 990, Part VI, Line 15b Process to establish compensation of other employees THE BROAD INSTITUTE MOST RECENTLY ENGAGED A CONSULTING FIRM TO CONDUCT AN INDEPENDENT STUDY FOR THE COMPENSATION OF CERTAIN OFFICERS AND KEY EMPLOYEES IN 2022 AND 2024. THE STUDY FINDINGS WERE PRESENTED TO THE LEADERSHIP, PERSONNEL POLICY AND BOARD GOVERNANCE COMMITTEE FOR REVIEW AND APPROVAL. THE BOARD OF DIRECTORS' DELIBERATIONS AND DECISIONS WERE CONTEMPORANEOUSLY DOCUMENTED. Form 990, Part VI, Line 19 Required documents available to the public THE INSTITUTE'S AUDITED FINANCIAL STATEMENTS ARE ATTACHED TO THE ANNUALLY FILED MASSACHUSETTS FORM PC, WHICH IS AVAILABLE TO THE PUBLIC. THE INSTITUTE'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE TO THE PUBLIC UPON REQUEST. Form 990, Part VII, Section A OFFICER TITLES LAURIE PESSAH IS AN OFFICER AT THE BROAD INSTITUTE. HER TITLE IS BOARD OF DIRECTORS ADMINISTRATOR, DIRECTOR OF SPECIAL PROJECTS, AND ASSISTANT CLERK. Form 990, Part VIII, Line 2f Other Program Service Revenue Symposium sponsorship - Total Revenue: 80021, Related or Exempt Function Revenue: 80021, Unrelated Business Revenue: , Revenue Excluded from Tax Under Sections 512, 513, or 514: ; - Total Revenue: 1695587, Related or Exempt Function Revenue: 1695587, Unrelated Business Revenue: , Revenue Excluded from Tax Under Sections 512, 513, or 514: ; Form 990, Part XI, Line 9 Other changes in net assets or fund balances THE INSTITUTE RECOGNIZED CHANGES IN THE INSTITUTE'S BENEFICIAL INTEREST IN TRUST OF $161,567 IN NONOPERATING ACTIVITIES IN ITS FINANCIAL STATEMENTS. - 161567; REVERSAL OF GRANT EXPENSES FOR $544,938 ARE REPORTED AS CONTRA EXPENSES IN THE INSTITUTE'S FINANCIAL STATEMENTS. - 544938; THE INSTITUTE RECOGNIZED A GAIN OF $9,665,766 FROM THE COUNT ME IN, INC. MERGER IN NONOPERATING ACTIVITIES IN ITS FINANCIAL STATEMENTS. - 9665766; THE INSTITUTE RECOGNIZED A LOSS OF $716,025 ON UNCOLLECTIBLE PLEDGES IN NONOPERATING ACTIVITIES IN ITS FINANCIAL STATEMENTS. - -716025; THE INSTITUTE RECOGNIZED A LOSS OF $12,079,358 ON UNCOLLECTIBLE GRANTS IN OPERATING ACTIVITIES IN ITS FINANCIAL STATEMENTS. - -12079358; Total - -2423112; Broad Clinical Labs LLC 415 Main Street Cambridge MA 02142 352469571 Sequencing Services MA 6319573 184980314 Broad Institute Genome Bridge LLC 415 Main Street Cambridge MA 02142 900984758 Inactive MA 0 0 Broad Institute The Stanley Fund for the Broad Institute 415 Main Street Cambridge MA 02142 465574304 Support Org. MA 501(c)(3) Type I Broad Institute true false false false false false false false false false false false false false false false false false false false